The frequency of p53 and Pten dual mutation in tumor tissues was as high as 45% at 6 months(n = 20) and 75% at 8 months (n = 20) post injection, suggesting an increase of p53 and Pten mutation frequency over time which implicated the selective growth advantage of mutant cells. Here, TP53 is linked to neoplasm.